TARA Stock Analysis: Buy, Sell, or Hold?
TARA - Protara Therapeutics, Inc. Common Stock
$4.04
0.22 (5.76%)
▲
5d:
+0.25%
30d:
-10.62%
90d:
-22.46%
BUY
HIGH Confidence
Analysis Updated: Jul 1, 2026 12:00 AM ET
Earnings: Aug 10, 2026
Get Alerted When TARA Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
✅ BUY SIGNAL: TARA shows strong fundamentals and good volume confirmation. Solid entry point despite slightly low pricing.
✅ BUY SIGNAL: TARA shows strong fundamentals and good volume confirmation. Solid entry point despite slightly low pricing.
In-depth Analysis How we analyze
Valuation Analysis: TARA is currently trading at $4.04, which is considered slightly low relative to its 30-day fair value range of $3.84 to $4.47.
Technical Outlook: Technically, TARA is in a strong downtrend. The price is currently testing key support at $3.94. A bounce from this level would confirm strength, while a break below could signal further downside. The stock is showing strong short-term momentum, up 5.8% recently.
Market Sentiment: The stock shows a mixed technical setup (45/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $26.57 (+557.7%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Technical Outlook: Technically, TARA is in a strong downtrend. The price is currently testing key support at $3.94. A bounce from this level would confirm strength, while a break below could signal further downside. The stock is showing strong short-term momentum, up 5.8% recently.
Market Sentiment: The stock shows a mixed technical setup (45/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $26.57 (+557.7%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Quick Decision Summary
Current Position
SLIGHTLY LOW
Historical Trading Range
$3.84 -
$4.47
Company Quality Score
51/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
87.9%
All Signals
- BULLISH: Price oversold vs 30-day range
- NEUTRAL: Mixed technical signals (45/100)
- BULLISH: High volume confirmation
- BULLISH: Strong upward momentum (+5.8%)
- BULLISH: Trading 557.7% below Wall St target ($26.57)
Trading Range Analysis
30-Day Trading Range
$3.84 -
$4.47
Current vs Trading Range
SLIGHTLY LOW
Support & Resistance Levels
Support Level
$3.95
Resistance Level
$4.97
Current Trend
Strong Downtrend
Technical data as of
Jun 9, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-2.46
Wall Street Target
$26.57
(+557.7%)
Share & Embed Analysis
Last updated: July 02, 2026 2:32 AM ET
Data refreshes hourly during market hours. Next update: 3:32 AM
Data refreshes hourly during market hours. Next update: 3:32 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is TARA showing a specific setup today?
Insider Activity (6 Months)
0
Buys
2
Sells
Net
INSIDERS SELLING
Recent Transactions
Jacqueline Zummo
SELL
1134 shares
2026-04-08
Jacqueline Zummo
SELL
22598 shares
2026-04-01
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
ALNY
Alnylam Pharmaceuticals … |
STRONG BUY
30 analysts |
$436 | 58 HOLD |
|
RARE
Ultragenyx |
STRONG BUY
20 analysts |
$52 | 58 HOLD |
|
BBIO
BridgeBio Pharma Inc |
STRONG BUY
19 analysts |
$102 | 58 HOLD |
|
NRIX
Nurix Therapeutics Inc |
STRONG BUY
18 analysts |
$31 | 56 HOLD |
|
BHVN
Biohaven Ltd. |
STRONG BUY
16 analysts |
$22 | 58 HOLD |
